» Articles » PMID: 39005062

Biogenesis and Function of CircRNAs in Pulmonary Fibrosis

Overview
Journal Curr Gene Ther
Specialties Genetics
Pharmacology
Date 2024 Jul 15
PMID 39005062
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary fibrosis is a class of fibrosing interstitial lung diseases caused by many pathogenic factors inside and outside the lung, with unknown mechanisms and without effective treatment. Therefore, a comprehensive understanding of the molecular mechanism implicated in pulmonary fibrosis pathogenesis is urgently needed to develop new and effective measures. Although circRNAs have been widely acknowledged as new contributors to the occurrence and development of diseases, only a small number of circRNAs have been functionally characterized in pulmonary fibrosis. Here, we systematically review the biogenesis and functions of circRNAs and focus on how circRNAs participate in pulmonary fibrogenesis by influencing various cell fates. Meanwhile, we analyze the current exploration of circRNAs as a diagnostic biomarker, vaccine, and therapeutic target in pulmonary fibrosis and objectively discuss the challenges of circRNA- based therapy for pulmonary fibrosis. We hope that the review of the implication of circRNAs will provide new insights into the development circRNA-based approaches to treat pulmonary fibrosis.

References
1.
Pugashetti J, Adegunsoye A, Wu Z, Lee C, Srikrishnan A, Ghodrati S . Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022; 207(1):69-76. PMC: 9952866. DOI: 10.1164/rccm.202201-0124OC. View

2.
Ishida Y, Kuninaka Y, Mukaida N, Kondo T . Immune Mechanisms of Pulmonary Fibrosis with Bleomycin. Int J Mol Sci. 2023; 24(4). PMC: 9958859. DOI: 10.3390/ijms24043149. View

3.
Podolanczuk A, Thomson C, Remy-Jardin M, Richeldi L, Martinez F, Kolb M . Idiopathic pulmonary fibrosis: state of the art for 2023. Eur Respir J. 2023; 61(4). DOI: 10.1183/13993003.00957-2022. View

4.
Raghu G, Remy-Jardin M, Richeldi L, Thomson C, Inoue Y, Johkoh T . Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022; 205(9):e18-e47. PMC: 9851481. DOI: 10.1164/rccm.202202-0399ST. View

5.
Raghu G, Remy-Jardin M, Myers J, Richeldi L, Ryerson C, Lederer D . Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5):e44-e68. DOI: 10.1164/rccm.201807-1255ST. View